Diagnosis & Treatment

Treatment revolution for pediatric psoriasis on horizon

Recent spectacular advances in the treatment of adult psoriasis haven't yet reached the pediatric patient population in the United States because of an early overabundance of caution on the part of the Food and Drug Administration. But the agency has subsequently altered its stance, and the wow-factor medications are on their way, Lawrence F. Eichenfield, MD, predicted in an audio interview at the SDEF Hawaii Dermatology Seminar provided by the Global Academy for Medical Education/Skin Disease Education Foundation.
Read More